Raltegravir Concentrations in Cerebrospinal Fluid

Written by Scott Letendre, M.D.

Agency: Merck Pharm
Agency Award Number: 33132

This project will estimate the penetration of Raltegravir into the brain by
measuring its concentrations in CSF and estimate the antiviral effectiveness
in the brain of Raltegravir by measuring HIV RNA levels in CSF.

 

Copyright ©2022 HIV Neurobehavioral Research Program | University of California, San Diego
For questions regarding this site, please contact the webmaster